Complementing this salvage route, formate supplementation drives de novo purine synthesis in tumor-infiltrating T cells and augments anti-PD-1 efficacy in vivo, underscoring a metabolic axis that can synergize with inosine support [52]. Here, PDCD1 is linked to neoplasm.